Overall performance of a drug–drug interaction clinical decision support system¶
Van De Sijpe, G., Quintens, C., Walgraeve, K., Van Laer, E., Penny, J., De Vlieger, G., Schrijvers, R., et al. (2022). Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey. BMC Medical Informatics and Decision Making, 22.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Conjunctive Path Activation
- The interventions are the prime's: combination-aware monitoring — interaction-checking systems that alert on joint states (this drug plus that drug plus this lab pattern) rather than individual thresholds — and breaking the AND at the most modifiable edge, typically by removing or substituting one of the interacting drugs.
This sourceDrug-drug-interaction clinical-decision-support evaluation showing that incorporating patient-specific data (laboratory values, concomitant medication, demographics) yields fewer but more relevant alerts — alerting on joint drug-plus-lab states rather than single thresholds, the combination-aware monitoring the prime describes.
- The interventions are the prime's: combination-aware monitoring — interaction-checking systems that alert on joint states (this drug plus that drug plus this lab pattern) rather than individual thresholds — and breaking the AND at the most modifiable edge, typically by removing or substituting one of the interacting drugs.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:5f38b28331bd · see in the full table